Home Eli Lilly and Price Target Raised to $93.00 at Leerink Swann
 

Keywords :   


Eli Lilly and Price Target Raised to $93.00 at Leerink Swann

2015-09-08 00:18:56| Biotech - Topix.net

The brokerage currently has an "outperform" rating on the stock. Leerink Swann's price objective points to a potential upside of 15.79% from the company's previous close.

Tags: price target raised eli

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.09AWA releases Glue-Applied Label Market Report 2024
23.09Hurricane John Graphics
23.09Hurricane John Forecast Discussion Number 5
23.09Hurricane John Wind Speed Probabilities Number 5
23.09Eastern North Pacific Tropical Weather Outlook
23.09Hurricane John Forecast Advisory Number 5
23.09Hurricane John Public Advisory Number 5
23.09Potential Tropical Cyclone Nine Public Advisory Number 1A
More »